<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35094">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01845220</url>
  </required_header>
  <id_info>
    <org_study_id>81276</org_study_id>
    <nct_id>NCT01845220</nct_id>
  </id_info>
  <brief_title>Prevention of Alcohol Intolerance</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paul Talalay, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine whether Asians who are especially sensitive to alcohol
      exposure can be protected by boosting their activities of an alcohol disposing enzyme. This
      will be accomplished by administering broccoli sprouts that are rich in an agent that
      increases protective enzyme activity.  The test system involves applying alcohol patches to
      the skin and measuring skin redness.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Skin Erythema (Skin redness)</measure>
    <time_frame>30 minutes after alcohol skin challenge and every 30 minutes for at least 2 hours.</time_frame>
    <safety_issue>No</safety_issue>
    <description>For three days in a row, volunteers will receive skin treatments with broccoli sprout extract.  On day four, their skin will be measured for a baseline skin color reading.  Immediately following this reading, the treated areas of the skin will be challenged with 70 percent alcohol and the redness of the skin will again be measured every 30 minutes for the following two hours for skin color changes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Alcohol Sensitivity</condition>
  <arm_group>
    <arm_group_label>Broccoli Sprout Extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will act as his/her own control and receive both treatment and placebo on adjacent skin regions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Each subject will act as his/her own control and receive both treatment and placebo on adjacent skin regions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Broccoli Sprout Extract</intervention_name>
    <description>150 nanomol of sulforaphane/cm2 of skin in 80% acetone for 3 applications on 3 successive days prior to alcohol challenge</description>
    <arm_group_label>Broccoli Sprout Extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>80% acetone</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-70 years old,

          -  sensitive to alcohol on the skin, Japanese

        Exclusion Criteria:

          -  recent skin abnormalities /tanning
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paul Talalay, M.D.</last_name>
    <phone>4109553499</phone>
    <email>ptalalay@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Scott L Wehage, M.S.</last_name>
    <phone>4109551578</phone>
    <email>swehage1@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Talalay, M.D.</last_name>
      <phone>410-955-3499</phone>
      <email>ptalalay@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Talalay, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 12, 2014</lastchanged_date>
  <firstreceived_date>April 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Paul Talalay, M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Broccoli sprouts</keyword>
  <keyword>alcohol sensitivity</keyword>
  <keyword>sulforaphane</keyword>
  <keyword>alcohol metabolism</keyword>
  <keyword>in the Asian Community</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sulforafan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
